ArticleAmerican journal of cancer research2019

BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening.

Jie Ding et al.PubMed ↗Full text ↗

No numbers read from the abstract.